Mark J. Rosenblum
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark J. Rosenblum
Mark J. Rosenblum is recorded as CFO at Decoy Therapeutics Inc. (DCOY). Decoy Therapeutics Inc. reported in an 8-K filed August 18, 2025 that Mark J. Rosenblum was appointed acting Chief Executive Officer, effective August 17, 2025. The proxy statement of Decoy Therapeutics Inc. reports total compensation of $350,422 for Mark J. Rosenblum in fiscal 2024, including a base salary of $330,000. Disclosed compensation is on record for 2 fiscal years.
“On August 17, 2025, the Board of Directors (the "Board") of Salarius Pharmaceuticals, Inc. (the "Company") appointed Mark J. Rosenblum as the acting Chief Executive Officer of the Company and designated him as the Company's "principal executive officer" (the "Acting CEO Appointment").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2025-11-07
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Decoy Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Frederick E. Pierce CEO, Board Member
- Arnold C. Hanish Board Member
- David J. Arthur Board Member
- Jonathan Lieber Board Member
- Patricia Gauthier Board Member
- Paul Lammers Board Member
- Tess Burleson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Decoy Therapeutics Inc. (DCOY) | Executive Vice President, Finance and Chief Financial Officer | $330,000 | $350,422 |
| 2023 | Decoy Therapeutics Inc. (DCOY) | Executive Vice President, Finance and Chief Financial Officer | $330,000 | $355,760 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.